Headache News and Research

Latest Headache News and Research

FDA approves new drug to treat MS in pediatric patients

The U.S. Food and Drug Administration today approved Gilenya (fingolimod) to treat relapsing multiple sclerosis (MS) in children and adolescents age 10 years and older. This is the first FDA approval of a drug to treat MS in pediatric patients.

14 May 2018

FDA grants approval for two drugs administered together to treat aggressive form of thyroid cancer

The U.S. Food and Drug Administration approved Tafinlar (dabrafenib) and Mekinist (trametinib), administered together, for the treatment of anaplastic thyroid cancer (ATC) that cannot be removed by surgery or has spread to other parts of the body (metastatic), and has a type of abnormal gene, BRAF V600E (BRAF V600E mutation-positive).

8 May 2018

Expert researcher unravels mystery of 12th century Sultan's illness

Saladin may not be well known in the West, but even 800 years after his death, he remains famous in the Middle East. Born in 1137, he rose to become the Sultan of an enormous area that now includes Egypt, Syria, parts of Iraq, Lebanon, Yemen and other regions of North Africa.

7 May 2018

Study examines effectiveness of MDMA-assisted psychotherapy in service personnel with PTSD

A new experimental study has tested the safety and effectiveness of MDMA-assisted psychotherapy in 26 service personnel with post-traumatic stress disorder (PTSD).

2 May 2018

New report reveals socioeconomic impact of migraine in the UK

The equivalent of 86 million workdays are lost to migraine each year and close to £1 billion is spent on healthcare costs associated with the condition. It affects more than 23 per cent of adults with almost 200,000 attacks happening in the UK every day - making migraine the most common neurological reason for accident and emergency attendance.

27 Apr 2018

New optogenetic tools show promise in treating cardiovascular, neuropsychiatric disorders

You've heard of "nature versus nurture," and philosophers argue about which is more important. But how does this work on the cellular level?

27 Apr 2018

Studies offer leads for new approaches to treat neurological problems

Technological advances have ushered in a new era of discovery in neuroscience. The Experimental Biology 2018 meeting will feature an array of research findings on the brain and nervous system.

23 Apr 2018

New drug for migraine in the pipeline

According to a pilot study results released yesterday (17th of April 2018), a new drug may help provide relief to people with migraine that is unsuccessfully treated with the currently available drugs.

18 Apr 2018

Middle ear infection can lead to deadly neurological complications

While antibiotics have greatly reduced the dangers of ear infections, serious neurological complications, including hearing loss, facial paralysis, meningitis and brain abscess still occur, according to an article in the journal Current Neurology and Neuroscience Reports.

16 Apr 2018

Researcher explores how children develop immunity to malaria as they grow older

Across the world, over 200 million cases of malaria and nearly 500,000 deaths from the disease occur annually--more than 90 percent of which happen in Africa. Children in Africa can be diagnosed with malaria two or three times a year, a rate that decreases as they become older and develop immunity. But the way children generate and maintain this immunity remains a mystery.

11 Apr 2018

Mild head injury increases risk for long-term headaches

"Most people with a mild head injury take off work for a week and then forget about it, but some end up with long-term ailments like headaches," says Lena Hoem Nordhaug, a PhD candidate in neuromedicine at the Norwegian University of Science and Technology.

10 Apr 2018

Hottest pepper gives man “thunderclap”

An unidentified 34 year old man reportedly ate a Carolina Reaper – one of the hottest rates peppers in the world, during a contest. What followed was a series of intense headaches and retching in the man. The headaches are typically termed 'thunderclap headaches'. The case study was published this week by the doctors attending the man in the journal BMJ Case Reports.

10 Apr 2018

App-based self-acupressure benefits women with menstrual pain

Can acupressure achieve a sustained reduction in menstrual pain? Is an app-based self-care program particularly attractive to young women? These questions addressed in a new study by researchers from Charité - Universitätsmedizin Berlin, the results of which have been published in the American Journal of Obstetrics and Gynecology.

4 Apr 2018

Getting better prepared to treat in-flight medical emergencies

"Ladies and gentlemen, is there a physician on board?" The flight attendant on a flight from Rwanda to Turkey made the announcement no one wants to hear, and Rachel Zang, MD, an Emergency Medicine resident at the Hospital of the University of Pennsylvania, jumped into action.

31 Mar 2018

FDA grants accelerated approval to leukemia drug for patients with MRD-positive ALL

The U.S. Food and Drug Administration granted accelerated approval to Blincyto (blinatumomab) to treat adults and children with B-cell precursor acute lymphoblastic leukemia (ALL) who are in remission but still have minimal residual disease (MRD).

30 Mar 2018

Survey: Americans turn to foods, drinks, herbs and bedtime rituals to get a good night's sleep

A new survey from Sleep Cycle, the best-selling alarm clock application, reveals that Americans turn to a number of foods, drinks, herbs and bedtime rituals to get a good night's sleep.

29 Mar 2018

Modifying Oncolytic Adenoviruses to Target Pancreatic Cancer

Pancreatic cancer is one of the less common but deadliest cancers. Modified oncolytic adenoviruses represent an alternative to chemotherapy and targeted therapies, which have a high mortality rate.

9 Mar 2018

FDA approves new tests to detect tickborne parasite in human plasma and whole blood samples

The U.S. Food and Drug Administration today approved the Imugen Babesia microti Arrayed Fluorescent Immunoassay, for the detection of antibodies to Babesia microti (B. microti) in human plasma samples, and the Imugen Babesia microti Nucleic Acid Test (NAT), for the detection of B. microti DNA in human whole blood samples.

7 Mar 2018

Glass walls and headaches at Apple Park

Apple has a beautiful nearly all-glass office at Cupertino. It almost looks like a futuristic spaceship. But in reality, the all glass model is giving the employees a real and literal headache as they repeatedly bump into the glass walls.

5 Mar 2018

Lassa fever strikes in Nigeria - high rates of fatality with no cure and no vaccine

Nigeria has been affected with an outbreak of the deadly Lassa fever since the start of this year. This disease typically has a high rate of fatality, no known cure and no vaccines have been developed against it yet. This is an unprecedented outbreak of this disease that is spreading faster than before. It is infecting more individuals than health workers can handle with their limited resources, say official sources.

5 Mar 2018